Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC N-(1,3-dimethyl-2-oxo-6-piperidin-1-ylbenzimidazol-5-yl)-2-methoxybenzamide | 901245-65-6 | MFCD14744183 | 98.3% | 394.47 g·mol-1 | C22H26N4O3 | 10 MG
SDP

Catalog No. 5000294701
Encompass_Preferred

GSK-5959 is a potent, selective, cell-permeable small-molecule inhibitor of the BRPF1 bromodomain with an IC50 of approximately 80 nM. It is used as a research tool to probe BRPF1-dependent chromatin regulation in biochemical and cellular assays. Molecular formula C22H26N4O3, molecular weight 394.47 g·mol-1, CAS 901245-65-6.

  • Potent and selective BRPF1 bromodomain inhibition.
  • Cell-permeable for cellular assay applications.
  • Suitable for biochemical assays and target validation studies.
  • Documented physicochemical identifiers for reproducibility.
  • Provided in milligram-scale quantities for research use.

Catalog No. 50-002-94701 Supplier Medchemexpress LLC Supplier No. HY1866510MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GSK-5959 is a potent, selective, cell-permeable small-molecule inhibitor of the BRPF1 bromodomain with an IC50 of approximately 80 nM. It is used as a research tool to probe BRPF1-dependent chromatin regulation in biochemical and cellular assays. Molecular formula C22H26N4O3, molecular weight 394.47 g·mol-1, CAS 901245-65-6.

  • Potent and selective BRPF1 bromodomain inhibition.
  • Cell-permeable for cellular assay applications.
  • Suitable for biochemical assays and target validation studies.
  • Documented physicochemical identifiers for reproducibility.
  • Provided in milligram-scale quantities for research use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.